IRIS Accounts Production v25.1.0.734 12844254 director 1.9.23 31.8.24 31.8.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128442542023-08-31128442542024-08-31128442542023-09-012024-08-31128442542022-08-31128442542022-09-012023-08-31128442542023-08-3112844254ns15:EnglandWales2023-09-012024-08-3112844254ns14:PoundSterling2023-09-012024-08-3112844254ns10:Director12023-09-012024-08-3112844254ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3112844254ns10:SmallEntities2023-09-012024-08-3112844254ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3112844254ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3112844254ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3112844254ns10:FullAccounts2023-09-012024-08-311284425412023-09-012024-08-3112844254ns10:OrdinaryShareClass12023-09-012024-08-3112844254ns5:CurrentFinancialInstruments2024-08-3112844254ns5:CurrentFinancialInstruments2023-08-3112844254ns5:Non-currentFinancialInstruments2024-08-3112844254ns5:Non-currentFinancialInstruments2023-08-3112844254ns5:ShareCapital2024-08-3112844254ns5:ShareCapital2023-08-3112844254ns5:RetainedEarningsAccumulatedLosses2024-08-3112844254ns5:RetainedEarningsAccumulatedLosses2023-08-3112844254ns10:RegisteredOffice2023-09-012024-08-3112844254ns5:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3112844254ns5:PatentsTrademarksLicencesConcessionsSimilar2023-09-012024-08-3112844254ns5:PatentsTrademarksLicencesConcessionsSimilar2023-08-3112844254ns5:PatentsTrademarksLicencesConcessionsSimilar2024-08-3112844254ns5:PatentsTrademarksLicencesConcessionsSimilar2023-08-3112844254ns5:Non-currentFinancialInstruments2023-09-012024-08-3112844254ns10:OrdinaryShareClass12024-08-31128442541ns10:Director12023-08-31128442541ns10:Director12022-08-31128442541ns10:Director12023-09-012024-08-31128442541ns10:Director12022-09-012023-08-31128442541ns10:Director12024-08-31128442541ns10:Director12023-08-31
REGISTERED NUMBER: 12844254 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st August 2024

for

Safe Iv Ltd

Safe Iv Ltd (Registered number: 12844254)






Contents of the Financial Statements
for the Year Ended 31st August 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Safe Iv Ltd (Registered number: 12844254)

Balance Sheet
31st August 2024

31.8.24 31.8.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 84,222 74,101

CURRENT ASSETS
Cash at bank 527 487

CREDITORS
Amounts falling due within one year 5 1,742 1,430
NET CURRENT LIABILITIES (1,215 ) (943 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

83,007

73,158

CREDITORS
Amounts falling due after more than one year 6 139,874 116,790
NET LIABILITIES (56,867 ) (43,632 )

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings (56,967 ) (43,732 )
SHAREHOLDERS' FUNDS (56,867 ) (43,632 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st August 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20th May 2025 and were signed by:





Dr S P Gill - Director


Safe Iv Ltd (Registered number: 12844254)

Notes to the Financial Statements
for the Year Ended 31st August 2024

1. COMPANY INFORMATION

Safe Iv Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12844254

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Going concern
These financial statements are prepared on the going concern basis despite the company having negative reserves. However, the company retains the full support of the directors and the directors have a reasonable expectation that the company has sufficient resources to continue in operational existence for the foreseeable future. The company has also been granted a patent and intellectual property on a product designed by the director, the director is of the opinion that income from the patent will commence in the foreseeable future.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

Safe Iv Ltd (Registered number: 12844254)

Notes to the Financial Statements - continued
for the Year Ended 31st August 2024

4. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1st September 2023 98,090
Additions 22,144
At 31st August 2024 120,234
AMORTISATION
At 1st September 2023 23,989
Amortisation for year 12,023
At 31st August 2024 36,012
NET BOOK VALUE
At 31st August 2024 84,222
At 31st August 2023 74,101

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Directors' current accounts 1,148 836
Accrued expenses 594 594
1,742 1,430

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.8.24 31.8.23
£    £   
Other creditors 139,874 116,790

Included in creditors due in more than one year is a loan from a company, Steven Gill Anaesthetic Services Limited, of which the director is also a director and majority shareholder. All transactions were made at arms length.

The loan will be repaid once Safe IV Ltd is earning income from either the sale of the medical device or the patent for that device which ever is the sooner.

At this point no interest is to be charged on the loan.

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.24 31.8.23
value: £    £   
100 Ordinary £1 100 100

The Ordinary Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

Safe Iv Ltd (Registered number: 12844254)

Notes to the Financial Statements - continued
for the Year Ended 31st August 2024

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st August 2024 and 31st August 2023:

31.8.24 31.8.23
£    £   
Dr S P Gill
Balance outstanding at start of year (836 ) (524 )
Amounts repaid (312 ) (312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,148 ) (836 )

The loan is repayable on demand and no interest was charged during the period.

9. CONTROL

The ultimate controlling party is Dr S Gill by virtue of holding 100% of the voting share capital.